维普期刊资源整合服务平台（V6.5）

78篇 您的检索式：作者名="PAPAKOSTAS GI"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Quality of life assess- ments in Major Depressive Disorder:a review of the literature显示文摘	Papakostas GI Petersen T Mahal Y	2004	General Hospital Psychiatry2004，26，：	1
2	A typical anti- psychotic augmentation in major depress- ive disorder: a recta-analysis ofplacebocontroll- ed randomized trials显示文摘	Nelson JC Papakostas GI	2009	Am J Psychiatry2009，166，9：	1
3	Psychosocial func- tioning during the treatment of major depressive disorder with fluox- etine显示文摘	Papakostas GI Petersen T Denninger JW	2004	Clin Psychopharmacol2004，24，5：	1
4	The relationship between serum folate,vitamin B12,and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine显示文摘	Papakostas GI Petersen T Lebowitz BD	2005	Int J Neuropsychopharmacol2005，8，4：	1
5	Efficacy of antidepressants for dysthymia: a meta-analysis of place- bo-controlled randomized trials 显示文摘	Levkovitz Y Tedeschini E Papakostas GI	2011	J Clin Psychia2011，72，4：	1
6	A meta-anal- ysis of clinical trials comparing reboxetine, a norepineph- rine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder显示文摘	Papakostas GI Nelson JC Kasper S	2008	Eur Neuropsyehopharmacol2008，18，2：	1
7	Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder显示文摘	Sonawalla S Papakostas GI Petersen T	2002	Psychosomatics2002，43，：	1
8	Serum folate,vitamin B12,and homoeysteine in major depressive disorder,Part 2:predictors of relapse during the continuation phase of pharmacotherapy显示文摘	Papakostas GI Petersen T Mischoulon D	2004	J Clin Psychiatry2004，65，80：	1
9	Testing anxious depression as a predictor and moderator of symptom improvement in major depressive disorder during treatment with escitalopram 显示文摘	PAPAKOSTAS GI LARSEN K	2010	Eur Arch Psychiatry Clin Neurosci2010，，：	1
10	Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder显示文摘	Papakostas GI McGrath P Stewart J		0，，01：	1
11	Folates and S-adenosylmethionine for major depressive disorder显示文摘	Papakostas GI Cassiello CF Iovieno N	2012	Can J Psychiatry2012，57，7：	1
12	Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual patient data from 10 double-blind, randomized clinical trials显示文摘	Papakostas GI Trivedi MH AlpertJE	2008	J Psychiatr Res2008，42，2：	1
13	Treatment-resistant depression显示文摘	Souery D Papakostas GI Trivedi MH	2006	J Clin Psychiatry2006，67，6：	1
14	Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder显示文摘	Papakostas GI	2009	J Clin Psychiatry2009，705，：	1
15	Testing anxious depression as a predictor and moderator of symptom improvement in major depressive disorder during treatment with escitalopram显示文摘	Papakostas GI Larsen K	2011	Eur Arch Psychiatry Clin Neurosci2011，261，3：	1
16	S-adenosyl-methionine in depression:a comprehensive review of the literature显示文摘	Papakostas GI Alpert JE Fava M	2003	Curr Psychiatry Rep2003，5，6：	1
17	S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder:a double-blind,randomized clinical trial显示文摘	Papakostas GI Mischoulon D Shyu I	2010	Am J Psychiatry2010，167，8：	1
18	Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorder 显示文摘	IOSIFESCU DV CLEMENTI - CRAVEN N PAPAKOSTAS GI	2010	Psychosom Med2010，67，5：	1
19	Folates and S-adenosylmethionine for major depressive disorder显示文摘	Papakostas GI Cassiello CF Iovieno N	2012	Can J Psychiatry2012，57，7：	1
20	Augmentation of antidepres- sants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis 显示文摘	Papakostas GI Shelton RC Smith J	2007	J Clin Psychiatry2007，68，6：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示